Related Experiment Video

Updated: Jun 8, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Pseudomonas aeruginosa: acute lung injury or ventilator-associated pneumonia?

L Berra1, J Sampson, J Wiener-Kronish

  • 1Department of Anesthesia Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. lberra@partners.org

Minerva Anestesiologica
|October 12, 2010
PubMed

Insights

Pseudomonas aeruginosa causes severe ventilator-acquired pneumonia (VAP) in at-risk populations. This review covers P. aeruginosa epidemiology, virulence, and immune evasion mechanisms in ventilated patients.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Pseudomonas aeruginosa is an opportunistic Gram-negative bacterium.
  • It is a common cause of multidrug-resistant ventilator-acquired pneumonia (VAP).
  • P. aeruginosa infections are linked to severe outcomes and increased mortality.

Purpose of the Study:

  • To review recent epidemiology of P. aeruginosa pneumonia.
  • To describe P. aeruginosa virulence factors contributing to infection.
  • To illustrate clinical outcomes and immune evasion strategies in ventilated patients.

Main Methods:

  • Literature review of epidemiological studies.
  • Analysis of P. aeruginosa virulence factors.
  • Examination of clinical outcomes and host immune response.

Main Results:

  • Identification of at-risk populations for P. aeruginosa pneumonia.
  • Description of key virulence factors enabling infection.
  • Understanding of clinical manifestations and immune evasion tactics.

Conclusions:

  • P. aeruginosa poses a significant threat in VAP cases.
  • Knowledge of virulence and immune evasion is crucial for patient management.
  • Further research can improve treatment strategies for P. aeruginosa VAP.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: